Equities

Hartalega Holdings Bhd

Hartalega Holdings Bhd

Actions
Health CareMedical Equipment and Services
  • Price (MYR)3.39
  • Today's Change-0.01 / -0.29%
  • Shares traded4.19m
  • 1 Year change+62.98%
  • Beta--
Data delayed at least 15 minutes, as of Jul 24 2024.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Hartalega Holdings Berhad is an investment holding company. The Company is engaged in the manufacture and sale of nitrile and latex gloves. The Company’s products include latex, nitrile, polychloroprene, polyisoprene and specialty gloves. Its nitrile gloves products include AMG Nitrile Powder Free, BDG Nitrile Powder Free, COATS Nitrile Powder Free, Nitrile Powder Free Extended Cuff Sterile, Nitrile Powder Free Sterile, Industrial Nitrile Powder Free Long Cuff, Nitrile Powder Free, Nitrile Powder Free Accelerator-Free, Nitrile Powder Free Aloe Coated, Nitrile Powder Free Long Cuff and Nitrile Powder Free Semi Long Cuff. The Company's latex gloves products include COATS Latex Powder Free, Surgical Latex Powder Free, Latex Powder Free, Latex Powder Free Long Cuff, Latex Powder Free Long Cuff, Latex Powder Free Polymer Coated and Latex Powdered. It also offers Polychloroprene Powder Free, Polyisoprene Powder Free Surgical Underglove and Polyisoprene Surgical Powder Free Outerglove.

  • Revenue in MYR (TTM)1.84bn
  • Net income in MYR12.72m
  • Incorporated2006
  • Employees7.56k
  • Location
    Hartalega Holdings BhdC-G-9, 1 Jalan Dataran SDKUALA LUMPUR 52200MalaysiaMYS
  • Phone+60 362771733
  • Fax+60 362802533
  • Websitehttps://hartalega.com.my/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Eyebright Medical Tchnlgy Beijing Co Ltd688.32m210.96m9.16bn2.07k43.476.43--13.301.731.735.6411.690.40031.995.19516,774.6011.519.9913.2711.1672.2481.2928.7434.662.48--0.133919.9164.1449.5930.6371.8038.83--
iRay Technology Co Ltd1.23bn391.79m10.01bn1.66k26.513.48--8.154.124.1212.9431.380.27321.153.221,152,519.008.6612.079.4213.8656.3055.5931.7134.515.3333.080.402331.5220.3133.51-5.2758.58107.96--
Top Glove Corporation Bhd2.16bn-519.96m10.18bn11.00k--1.71--4.72-0.0649-0.06490.26910.72620.297--9.46134,795.90-6.5824.37-7.6131.04--43.76-22.1725.881.62-140.700.074370.79-59.49-11.77-510.18---4.47--
Poly Medicure Ltd.803.79m150.52m10.91bn2.34k72.52--57.8613.5728.0728.07149.90------------13.16--16.1265.3658.1118.7316.69--31.45--15.1023.3617.6344.0531.6128.858.45
Shandong Weigao Group Medical Polymer Co8.50bn1.29bn10.91bn12.52k8.390.75695.721.280.47570.47573.145.270.39452.732.371,134,260.006.157.898.2310.0850.2155.0315.5818.652.1313.090.14830.03-3.778.47-27.576.33-2.9310.76
Hartalega Holdings Berhad1.84bn12.72m11.65bn7.56k911.532.5076.936.340.00370.00370.53791.360.348--7.50--0.379824.510.40928.28----1.0929.234.935.750.0151---23.74-8.26105.41-51.10-17.45--
MGI Tech Co Ltd1.81bn-423.01m11.73bn2.87k--2.19--6.47-1.57-1.576.7920.040.2720.88934.44984,637.40-6.35---7.28--60.63---23.36--4.04--0.0507---31.19---129.98------
QuantumPharm Inc-59.82bn-59.82bn11.87bn783.00------------------------------------------------30.80---33.08------
NIHON KOHDEN CORPORATION6.67bn511.23m12.26bn5.89k23.452.2119.551.84101.81101.811,322.981,079.200.98671.903.3637,682,230.007.578.669.6311.4050.1650.857.678.412.54--0.003627.527.454.42-0.49098.758.0511.75
Ansell Ltd7.47bn482.98m12.40bn14.41k22.321.4415.181.661.231.2319.1019.030.63121.848.15167,614.004.136.604.967.8937.9937.836.559.500.947511.460.241842.17-15.212.13-6.554.318.020.8306
Data as of Jul 24 2024. Currency figures normalised to Hartalega Holdings Bhd's reporting currency: Malaysian Ringgit MYR

Institutional shareholders

11.07%Per cent of shares held by top holders
HolderShares% Held
Kumpulan Wang Persaraanas of 30 Jun 2023109.67m3.20%
The Vanguard Group, Inc.as of 04 Jul 202464.05m1.87%
Principal Asset Management Bhd.as of 30 Jun 202346.01m1.34%
Norges Bank Investment Managementas of 31 Dec 202341.11m1.20%
Orbis Investment Management Ltd.as of 30 Jun 202333.65m0.98%
Public Mutual Bhd.as of 30 Jun 202326.70m0.78%
BlackRock Fund Advisorsas of 04 Jul 202417.43m0.51%
Dimensional Fund Advisors LPas of 04 Jul 202414.87m0.43%
Lembaga Tabung Hajias of 30 Jun 202313.30m0.39%
GIC Pte Ltd. (Investment Management)as of 30 Jun 202312.53m0.37%
More ▼
Data from 31 Dec 2023 - 18 Jul 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.